SphingoTec to Present at the LifeSci Partners' Summer Symposium


31.07.20 12:35
Meldung
 

DGAP-News: SphingoTec GmbH / Key word(s): Corporate Action/Conference
SphingoTec to Present at the LifeSci Partners' Summer Symposium

31.07.2020 / 12:30
The issuer is solely responsible for the content of this announcement.


Hennigsdorf/Berlin, Germany - July 31, 2020 - Diagnostics company SphingoTec GmbH ("SphingoTec") today announced that Dr Andreas Bergman, CEO, and Ferdinand von Humboldt, CFO, will be presenting a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners on August 4 and 5, 2020. 
<The company makes its assays for real-time assessment of kidney function, endothelial function and cardiac depression available on its fully integrated Nexus IB10 point-of-care platform.


Presentation Details:
Date:        August 4, 2020
Time:        3:30 p.m. CEST

Please click the following link to register: https://lifesci.events/SummerSymposium


About SphingoTec
SphingoTec GmbH ( "SphingoTec"; Hennigsdorf near Berlin, Germany) develops and markets innovative in-vitro diagnostic (IVD) tests for novel and proprietary biomarkers for the diagnosis, prediction and monitoring of acute medical conditions, such as sepsis, acute heart failure, circulatory shock, and acute kidney injury in order to support patient management and provide guidance for treatment strategies. SphingoTec's proprietary biomarker portfolio includes Bioactive Adrenomedullin(bio-ADM(R)), a unique biomarker for real-time assessment of endothelial function in conditions like sepsis or congestive heart failure, Proenkephalin (penKid(R)), a unique biomarker for real-time assessment of kidney function, and Dipeptidyl Peptidase 3 (DPP3), a unique biomarker for cardiac depression. IVD tests for SphingoTec's proprietary biomarkers are made available as sphingotest(R) microtiterplate tests as well as point-of-care tests on the Nexus IB10 immunoassay platform by SphingoTec's subsidiary Nexus Dx Inc. (San Diego, CA, USA) alongside a broad menu of established and commonly used tests for acute and critical care. 

For more information please visit our website: https://sphingotec.com/

Contact:
SphingoTec GmbH
Ferdinand von Humboldt
CFO 
+ 49 330 220 56 50
investors@sphingotec.com


LifeSci Advisors, LLC 
Guillaume van Renterghem
Managing Director
+33 (0)6 69 99 37 83
gvanrenterghem@lifesciadvisors.com
 


31.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


1107587  31.07.2020 

fncls.ssp?fn=show_t_gif&application_id=1107587&application_name=news&site_id=ariva


 

Breaking News

Weitere Meldungen
 
31.07 DGAP-NVR: Evotec SE: Ve.
31.07 DGAP-NVR: PAION AG: V.
31.07 Directors' Dealings: publity A.
31.07 Stimmrechtsanteile: INTERSH.
31.07 Custodian REIT plc : Total .
31.07 Coinsilium Group Limited: Fin.
31.07 CTS EVENTIM sichert inmit.
31.07 Reply SpA: Der Vorstand d.
31.07 thyssenkrupp Elevator starte.
31.07 Finanzbericht: TUI AG: Vora.
31.07 Stimmrechtsanteile: SPORTT.
31.07 TUI AG: Preliminary announc.
31.07 Directors' Dealings: flatex A.
31.07 Stimmrechtsanteile: Commerz.
31.07 SphingoTec to Present at th.
31.07 Marshal Lion Financial Group.
31.07 Directors' Dealings: FCR Imm.
31.07 ADM Energy PLC: Appointm.
31.07 DGAP-NVR: IMMOFINANZ A.
31.07 Logwin AG: Logwin angesic.
31.07 Stimmrechtsanteile: Epigenom.
31.07 Eve Sleep plc: Holding in Co.
31.07 Zulassungsfolgepflichten: Lin.
31.07 Directors' Dealings: Baader B.
31.07 Directors' Dealings: ADVA .
31.07 MediCoronabedingt vorsorglic.
31.07 Directors' Dealings: ADVA .
31.07 Stimmrechtsanteile: Philion S.
31.07 EQS-News: Nordea Bank Ab.
31.07 Directors' Dealings: Baader B.


Umfrage
 
Welche Social Networks nutzen Sie meistens?
Facebook
keine
Twitter
Xing
Linked in
Youtube
myspace
Google+
Wikipedia
andere


Stimmen: 99739 , Ergebnis


Kurssuche
Status: nicht eingeloggt

Registrieren | Passwort vergessen?
 
 
Im Bereich Nachrichten:
Deutsche Post: Alarmstufe rot!
Experte: Stefan Hofmann, STOCK-WORLD
Kolumnen
S&P 500 - Neue ...
Christian Zoller, www.boerse-daily.de (30.11.21)
Experte: Christian Zoller, www.boerse-daily.de
Nasdaq 100 – Robust in ...
HypoVereinsbank onema., (30.11.21)
Experte: HypoVereinsbank onemarkets,
Galan Lithium Limited ...
Miningscout.de, (30.11.21)
Experte: Miningscout.de,
DOW DAX an der 15000
Thomas Heydrich, Systemstradings.de (30.11.21)
Experte: Thomas Heydrich, Systemstradings.de
Die meistgehandelten ...
EUWAX Trends, Börse Stuttgart (30.11.21)
Experte: EUWAX Trends, Börse Stuttgart
Corona-Rücksetzer an den ...
DONNER & REUSCHEL., (30.11.21)
Experte: DONNER & REUSCHEL AG,
Hype um virtuelle ...
Stock-World Redaktion, STOCK-WORLD (30.11.21)
Experte: Stock-World Redaktion, STOCK-WORLD
Sinn über den Unsinn der ...
Ingrid Heinritzi, (30.11.21)
Experte: Ingrid Heinritzi,
BITCOIN – Wann kommen ...
Michael Neubauer, Global Investa (30.11.21)
Experte: Michael Neubauer, Global Investa
Lithium-Company Vulcan ...
GOLDINVEST.de, GOLDINVEST.de (30.11.21)
Experte: GOLDINVEST.de, GOLDINVEST.de
Omikron-Schock: Wie geht ...
wikifolio.com, (30.11.21)
Experte: wikifolio.com,
Lufthansa, Biontech, ...
Feingold-Research, (30.11.21)
Experte: Feingold-Research,
Niquet's World
Neues vom Portal
 
Rohstoff-Fonds: Chance oder Risiko?
Letzte Börsen-Meldung
 
Letzte Börsen-Analyse
 
Top-Klicks News
 
Top-Klicks Analysen